CLASS II ONGOING Device recall · Reported 12 Oct 2022 · FDA Enforcement Report

Introcan Safety FEP, 2.2x32MM-US, Product recalled by B Braun Medical

B Braun Medical is recalling Introcan Safety FEP, 2.2x32MM-US, distributed in 14 states. The recall was initiated on 1 Sep 2022 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesUDI-DI (GTIN): 04046963318154 Lot Number/Expiration Date: 22D04G8241 01 Apr 2027 22D07G8241 01 Apr 2027 22D07G8242 01 Apr 2027 22E30G8241 01 May 2027 22E30G8242 01 May 2027
Quantity recalled94,000 US

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0009-2023
FDA event ID
90830
Recalling firm
B Braun Medical, Breinigsville, PA
Classification
Class II
Status
Ongoing
Recall initiated
1 Sep 2022
FDA classified
6 Oct 2022
Reported
12 Oct 2022
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Packaging Defects

Timeline

1 Sep 2022Recall initiated by company
6 Oct 2022Classified by FDA+35 days
12 Oct 2022Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Potential for leakage at the catheter hub.

Packaging recalls include wrong labels, wrong products in the wrong bottle, missing leaflets, short-filled or empty capsules and seals that fail.

Product as listed by the FDA

Introcan Safety FEP 14G, 2.2x32MM-US, Product Code 4251890-02. A passive anti-needle device to provide venous or arterial access.

Where it was distributed

Domestic distribution to AZ CA FL GA MD MI MO MS NC NY OH PA TN TX WA. Foreign distribution to Canada

ArizonaCaliforniaFloridaGeorgiaMarylandMichiganMissouriMississippiNorth CarolinaNew YorkPennsylvaniaTennesseeTexasWashington

Questions about this recall

Why was it recalled?

Potential for leakage at the catheter hub.

Which lots are affected?

UDI-DI (GTIN): 04046963318154 Lot Number/Expiration Date: 22D04G8241 01 Apr 2027 22D07G8241 01 Apr 2027 22D07G8242 01 Apr 2027 22E30G8241 01 May 2027 22E30G8242 01 May 2027

Where was it sold?

Domestic distribution to AZ CA FL GA MD MI MO MS NC NY OH PA TN TX WA. Foreign distribution to Canada

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from B Braun Medical

All 447

Other Syringes & Needles recalls

All 1,060